Impact of polycystic ovary syndrome on selected indicators of in vitro fertilization and intracytoplasmic sperm injection treatment success

Journal of Women's Health

Volumn 18, Issue 5, 2009, Pages 717-723

  Beydoun, Hind A ^a,b   Stadtmauer, Laurel ^b   Zhao, Yueqin ^a   Russell, Helena ^b   Matson, David O ^a   Oehninger, Sergio ^b  

^a Graduate Program in Public Health   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; EMBRYO; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MEDICAL RECORD REVIEW; OOCYTE; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; COMORBIDITY; EMBRYO TRANSFER; FEMALE; HUMANS; INFERTILITY, FEMALE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; WOMEN'S HEALTH; YOUNG ADULT;

EID: 68349098831     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.1149     Document Type: Article

References (37)

1. Sheehan MT. Polycystic ovarian syndrome: Diagnosis and management. Clin Med Res 2004;2:13-27.
2. Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: Systematic review and meta-analysis. BMJ 2003;327:951-953.
3. Azziz R. How prevalent is metabolic syndrome in women with polycystic ovary syndrome? Natl Clin Pract Endocrinol Metab 2006;2:132-133.
4. Barber TM, McCarthy MI, Franks S, Wass JA. Metabolic syndrome in polycystic ovary syndrome. Endokrynol Pol 2007;58:34-41.
5. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:48-53.
6. Hahn S, Tan S, Sack S, et al. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2007;115:130-135.
7. Vignesh JP, Mohan V. Polycystic ovary syndrome: A component of metabolic syndrome? J Postgrad Med 2007;53:128-134.
8. Homburg R. The management of infertility associated with polycystic ovary syndrome. Reprod Biol Endocrinol 2003; 1:109.
9. Dennefors BL, Knutson F, Janson PO, Jansson I, Hamberger L. Ovarian steroid production in a woman with polycystic ovary syndrome associated with endometrial cancer. Acta Obstet Gynecol Scand 1985;64:387-392.
10. Guzick DS. Ovulation induction management of PCOS. Clin Obstet Gynecol 2007;50:255-267.
11. Hart R. Polycystic ovarian syndrome - Prognosis and treatment outcomes. Curr Opin Obstet Gynecol 2007;19:529-535.
12. Dunaif A. Insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2006;86 (Suppl 1):S13-14.
13. Goodarzi MO, Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril 2003; 80:255-258.
14. Plosker SM. Polycystic ovary syndrome and insulin resistance. Med Health RI 2003;86:12-15.
15. Schroder AK, Tauchert S, Ortmann O, Diedrich K, Weiss JM. Insulin resistance in patients with polycystic ovary syndrome. Ann Med 2004;36:426-439.
16. Al-Azemi M, Omu FE, Omu AE. The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet 2004;270:205-210.
17. Stadtmauer L, Oehninger S. Management of infertility in women with polycystic ovary syndrome: A practical guide. Treat Endocrinol 2005;4:279-292.
18. Dokras A, Baredziak L, Blaine J, Syrop C, VanVoorhis BJ, Sparks A. Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet Gynecol 2006; 108:61-69.
19. Lord JM, Norman R. Obesity, polycystic ovary syndrome, infertility treatment: Lifestyle modification is paramount. BMJ 2006;332:609.
20. Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002;10:551-554.
21. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
22. Abdalla H, Thum MY. Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH. Hum Reprod 2006;21:171-174.
23. Sartor BM, Dickey RP. Polycystic ovarian syndrome and the metabolic syndrome. Am J Med Sci 2005;330:336-342.
24. Zawedski J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens J, Haseltine F, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific, 1992:377-384.
25. Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med 2006;354:1139-1146.
26. Pasquali R, Casimirri F, Vicennati V. Weight control and its beneficial effect on fertility in women with obesity and poly-cystic ovary syndrome. Hum Reprod 1997;12 (Suppl 1):82-87.
27. Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Re-prod Update 2006;12:13-21.
28. Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001;16:2606-2609.
29. Salobir B, Prezelj J, Kocijancic A, Meden-Vrtovec H. Basal glucose level as an independent predictor of fertilization rate in patients without polycystic ovary syndrome included in an in vitro fertilization program. Wien Klin Wochenschrift 2002;114:454-457.
30. Fedorcsak P, Dale PO, Storeng R, Tanbo T, Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod 2001;16:1086-1091.
31. Kinney A, Kline J, Kelly A, Reuss ML, Levin B. Smoking, alcohol and caffeine in relation to ovarian age during the reproductive years. Hum Reprod 2007;22:1175-1185.
32. Buffet NC, Bouchard P. The neuroendocrine regulation of the human ovarian cycle. Chronobiol Int 2001;18:893-919.
33. Chabbert Buffet N, Djakoure C, Maitre SC, Bouchard P. Regulation of the human menstrual cycle. Front Neuro-endocrinol 1998;19:151-186.
34. Luborsky J, Llanes B, Roussev R, Coulam C. Ovarian antibodies, FSH and inhibin B: Independent markers associated with unexplained infertility. Hum Reprod 2000;15:1046-1051.
35. Lawson R, El-Toukhy T, Kassab A, et al. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: A life table analysis. Hum Reprod 2003;18:527-533.
36. Summaria V, Speca S, Mirk P. Ovarian factor infertility. Rays 1998;23:709-726.
37. Burger HG. Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition - An analysis of FSH, oestradiol and inhibin. Eur J Endocrinol 1994;130:38-42.